CSIMarket
 
Integrated Biopharma Inc  (INBP)
 

Integrated Biopharma Inc's Customers Performance

INBP



 
INBP's Source of Revenues During the corresponding time, Integrated Biopharma Inc saw a revenue deteriorated by -28.24 % year on year, sequentially revenue fell by -11.83 %. While revenue at the Integrated Biopharma Inc's corporate clients

List of INBP Customers




for the same period Integrated Biopharma Inc revnue deteriorated by -28.24 % year on year, sequentially revenue fell by -11.83 %.

List of INBP Customers

Integrated Biopharma Inc's Business Units
Europe    20.1 % of total Revenue
Contract Manufacturing    101.02 % of total Revenue
Other Nutraceutical Business    2.92 % of total Revenue
UNITED STATES    83.83 % of total Revenue
UNITED STATES Contract Manufacturing    80.91 % of total Revenue
UNITED STATES Other Nutraceutical Business    2.92 % of total Revenue
Non-US    20.52 % of total Revenue
Non-US Contract Manufacturing    20.1 % of total Revenue






Integrated Biopharma Inc's Comment on Sales, Marketing and Customers
















INBP's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Integrated Biopharma Inc 5.28 47.24 -1.65 50
SUBTOTAL 0.00 0.00 0.00 -

Sources: Integrated Biopharma Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Integrated Biopharma Inc’s corporate clients.
For your research, we’ve provided 9 tables on Integrated Biopharma Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.